Ac-RYYRIK-NH2 TFA acts as both a potent partial agonist for ORL1 when transfected in CHO cells (K d = 1.5 nM) and an endogenous ligand of ORL1. Moreover, it serves as a specific antagonist that inhibits G protein activation and competitively blocks the stimulation of [35S]-GTPgammaS binding to G proteins by nociceptin/orphanin FQ (noc/OFQ) in rat brain membranes and sections [1].
Molecular Weight:
1053.13
Formula:
C46H71F3N14O11
Target:
Opioid Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
